This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Cardiovascular Systems Past Earnings Performance
Past criteria checks 0/6
Key information
-54.5%
Earnings growth rate
-52.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 2.1% |
| Return on equity | -15.8% |
| Net Margin | -15.8% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate
Feb 03
We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely
Oct 12Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Aug 03Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?
Oct 09At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?
Sep 18Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?
Jun 24Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Jun 03We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow
Apr 29Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain
Feb 10Cardiovascular Systems misses on revenue
Feb 03Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares
Dec 11
Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Nov 06Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Cardiovascular Systems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 240 | -38 | 174 | 36 |
| 30 Sep 22 | 238 | -39 | 173 | 36 |
| 30 Jun 22 | 236 | -37 | 171 | 37 |
| 31 Mar 22 | 245 | -33 | 170 | 37 |
| 31 Dec 21 | 252 | -29 | 169 | 41 |
| 30 Sep 21 | 257 | -20 | 169 | 42 |
| 30 Jun 21 | 259 | -13 | 167 | 41 |
| 31 Mar 21 | 231 | -23 | 157 | 39 |
| 31 Dec 20 | 228 | -20 | 157 | 36 |
| 30 Sep 20 | 233 | -24 | 163 | 37 |
| 30 Jun 20 | 237 | -27 | 170 | 39 |
| 31 Mar 20 | 262 | -11 | 179 | 41 |
| 31 Dec 19 | 264 | -7 | 179 | 40 |
| 30 Sep 19 | 256 | -3 | 173 | 37 |
| 30 Jun 19 | 248 | 0 | 168 | 32 |
| 31 Mar 19 | 239 | 2 | 162 | 30 |
| 31 Dec 18 | 231 | 2 | 158 | 29 |
| 30 Sep 18 | 224 | 1 | 154 | 28 |
| 30 Jun 18 | 217 | 2 | 149 | 27 |
| 31 Mar 18 | 211 | -1 | 145 | 26 |
| 31 Dec 17 | 207 | -3 | 145 | 24 |
| 30 Sep 17 | 205 | -2 | 142 | 24 |
| 30 Jun 17 | 205 | -2 | 144 | 23 |
| 31 Mar 17 | 199 | -7 | 146 | 23 |
| 31 Dec 16 | 191 | -28 | 149 | 23 |
| 30 Sep 16 | 183 | -45 | 157 | 24 |
| 30 Jun 16 | 177 | -56 | 161 | 26 |
Quality Earnings: CSII is currently unprofitable.
Growing Profit Margin: CSII is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CSII is unprofitable, and losses have increased over the past 5 years at a rate of 54.5% per year.
Accelerating Growth: Unable to compare CSII's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CSII is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-5.5%).
Return on Equity
High ROE: CSII has a negative Return on Equity (-15.82%), as it is currently unprofitable.